发明授权
US08038992B2 Target for regulating multiple sclerosis 失效
调节多发性硬化症的目标

Target for regulating multiple sclerosis
摘要:
Methods are provided for decreasing demyelinating inflammatory disease in a subject by inhibiting the activity of chemokine-like receptor 1 (CMKLR1). Methods are also provided for screening for agents that find use in treating demyelinating inflammatory disease in a subject.
公开/授权文献
信息查询
0/0